Claims
- 1. A method for inhibiting the growth and or proliferation of cervical cancer cells comprising bringing Interleukin-20 (IL-20) into contact with the cervical cancer cells.
- 2. The method of claim 1 wherein the cervical cancer cells are treated with radiation in conjunction with IL-20.
- 3. The method of claim 1 wherein the cervical cancer cells are treated with one or more additional chemotherapeutic agents in conjunction with IL-20.
- 4. The method of claim 3 wherein the chemotherapeutic agent is selected from the group consisting of bleomycin, chlorambucil, epirubicin, 5-fluorouracil, ifosfamide, mitomycin, methotrexate, vincristine, cisplatin and vinblastine.
- 5. A method for treating a female mammal afflicted with cervical cancer comprising administering to said female mammal IL-20.
- 6. The method of claim 5 wherein the IL-20 is administered in conjunction with radiation.
- 7. The method of claim 5 wherein the IL-20 is administered in conjunction with a chemotherapeutic agent.
- 8. The method of claim 7 wherein the chemotherapeutic agent is selected from the group consisting of bleomycin, chlorambucil, epirubicin, 5-fluorouracil, ifosfamide, mitomycin, methotrexate, vincristine, cisplatin and vinblastine.
- 9. A method for inhibiting the proliferation or growth of human papillomavirus (HPV) comprising bringing IL-20 into contact with cells infected with HPV.
- 10. The method of claim 9 wherein the IL-20 is injected into a genital wart infected with HPV.
- 11. The method of claim 9 wherein the IL-20 is administered in conjunction with the consisting of interferon alpha, interferon beta, podophyllotoxin, podophyllin and 5-fluorouracil, trichloroacetic acid, and imiquimod.
- 12. The method of claim 9 wherein the IL-20 is administered in conjunction with electrocauterization, laser, cryotherapy, or surgical excision of the cells infected with HPV.
- 13. A method for treating an individual infected with HPV comprising administering to said individual a therapeutically effective amount of IL-20.
- 14. The method of claim 13 wherein said individual has genital warts or lesions infected with HPV and the IL20 is injected into the lesions or genital warts infected.
- 15. The method of claim 14 wherein said the IL-20 is injected into said warts in conjunction with electrocauterization, laser, cryotherapy, or surgical excision of the genital warts or lesions infected with HPV.
- 16. The method of claim 14 wherein the IL-20 is administered in conjunction with the consisting of interferon alpha, interferon beta, podophyllotoxin, podophyllin and 5-fluorouracil, trichloroacetic acid, and imiquimod.
Parent Case Info
[0001] This claims the benefit under 35 U.S.C. §119 (e) of U.S. Provisional Application No. 60/341,783 filed on Dec. 17, 2001.
Provisional Applications (1)
|
Number |
Date |
Country |
|
60341783 |
Dec 2001 |
US |